Consenso sobre el diagnóstico y el tratamiento de la alergia a las proteínas de la leche de vaca de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición

Toca, María del Carmen; Morais, Mauro Batista de; Vázquez-Frías, R.; Becker-Cuevas, D.J.; Boggio-Marzet, C.; Delgado-Carbajal, L.; Higuera-Carrillo, M.M.; Ladino, Liliana; Marchisone, Silvia; Messere, Gabriela; Ortiz, Gonzalo; Ortiz-Paranza, L.R.; Ortiz-Piedrahita, Catalina; Riveros-López, J.P.; Sosa, Patricia; Villalobos-Palencia, N.C.

doi:10.1016/j.rgmx.2022.03.007

Cited by 5 publications

(1 citation statement)

References 104 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…58 Other guidelines and consensuses have also recommended AAF as a second option or as first line, considering various situations. 8,29,59,60…”

Section: Amino Acid-based Formulas (Aaf)mentioning

confidence: 99%

Mexican consensus on cow’s milk protein allergy

Ramírez Mayans,

Ignorosa Arellano,

Toro Monjaraz

et al. 2024

Allergol Immunopathol

View full text Add to dashboard Cite

Background: The aim of this study is to present the current views of a diverse group of experts on the diagnosis and treatment of Cow’s Milk Protein Allergy (CMPA) in children under 2 years of age in Mexico. Material and methods: The study, led by a scientific committee of five experts in CMPA, was divided into six phases, including a modified Delphi process. A total of 20 panelists, all of whom were pediatric specialists, participated in administering a comprehensive 38-item questionnaire. The questionnaire was divided into two blocks: Diagnosis and Treatment (20 items each). Results: Consensus was reached on all the proposed items, with an agreement rate of over 70% for each of them. As a result, a diagnostic and treatment algorithm was developed that emphasized the reduction of unnecessary diagnostic studies and encouraged breastfeeding whenever possible. In cases where breast milk is not available, appropriate use of hypoallergenic formulas was recommended. In addition, recommendations on treatment duration and gradual reintroduction of cow’s milk protein were provided. Conclusions: The recommendations endorsed by 20 Mexican pediatricians through this study are applicable to everyday clinical practice, thereby enhancing the diagnosis and treatment of children under 2 years of age with CMPA. This, in turn, will foster improved health outcomes and optimize the utilization of healthcare resources.

show abstract

“…58 Other guidelines and consensuses have also recommended AAF as a second option or as first line, considering various situations. 8,29,59,60…”

Section: Amino Acid-based Formulas (Aaf)mentioning

confidence: 99%

Mexican consensus on cow’s milk protein allergy

Ramírez Mayans,

Ignorosa Arellano,

Toro Monjaraz

et al. 2024

Allergol Immunopathol

View full text Add to dashboard Cite

show abstract

Impairment of intestinal barrier associated with the alternation of intestinal flora and its metabolites in cow's milk protein allergy

Yu,

Yue,

Yang

et al. 2023

Microbial Pathogenesis

View full text Add to dashboard Cite

An ESPGHAN Position Paper on the Diagnosis, Management, and Prevention of Cow's Milk Allergy

Vandenplas

Broekaert

Domellöf

et al. 2024

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

A previous guideline on cow's milk allergy (CMA) developed by the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) was published in 2012. This position paper provides an update on the diagnosis, treatment, and prevention of CMA with focus on gastrointestinal manifestations. All systematic reviews and meta-analyses regarding prevalence, pathophysiology, symptoms, and diagnosis of CMA published after the previous ESPGHAN document were considered. Medline was searched from inception until May 2022 for topics that were not covered in the previous document. After reaching consensus on the manuscript, statements were formulated and voted on each of them with a score between 1 and 9. A score of ≥6 was arbitrarily considered as agreement. Available evidence on the role of dietary practice in the prevention, diagnosis and management of CMA was updated and recommendations formulated. CMA in exclusively breastfed infants exists, but is uncommon and suffers from over-diagnosis. CMA is also over-diagnosed in formula and mixed fed infants. Changes in stool characteristics, feeding aversion or occasional spots of blood in stool are common and in general should not be considered as diagnostic of CMA, irrespective of preceding consumption of cow's milk. Over-diagnosis of CMA occurs much more frequently than under-diagnosis; both have potentially harmful consequences. Therefore, the necessity of a challenge test after a short diagnostic elimination diet of 2-4 weeks is recommended as the cornerstone of the diagnosis. This position paper contains sections on nutrition, growth, cost and quality of life.

show abstract

Consenso sobre el diagnóstico y el tratamiento de la alergia a las proteínas de la leche de vaca de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición

Cited by 5 publications

References 104 publications

Mexican consensus on cow’s milk protein allergy

Mexican consensus on cow’s milk protein allergy

Impairment of intestinal barrier associated with the alternation of intestinal flora and its metabolites in cow's milk protein allergy

An ESPGHAN Position Paper on the Diagnosis, Management, and Prevention of Cow's Milk Allergy

Contact Info

Product

Resources

About